Loading clinical trials...
Loading clinical trials...
A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Diabetic Retinopathy Without Center Involved-Diabetic Macular Edema
Conditions
Interventions
No Intervention
Locations
19
United States
Retinal Research Institute, LLC
Phoenix, Arizona, United States
California Retina Consultants
Bakersfield, California, United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
American Institute of Research
Los Angeles, California, United States
Northern California Retina Vitreous Associates Medical Group Inc
Mountain View, California, United States
California Eye Specialists Medical Group, Inc
Pasadena, California, United States
Start Date
April 4, 2022
Primary Completion Date
May 1, 2028
Completion Date
May 1, 2028
Last Updated
June 18, 2025
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions